CHF12.36
0.82% today
SIX Swiss Exchange, Jul 17, 10:44 am CET
ISIN
CH1129677105
Symbol
MEDX
Sector

Medmix Stock price

CHF12.26
+1.84 17.66% 1M
+1.40 12.89% 6M
+3.46 39.32% YTD
-2.08 14.50% 1Y
-8.46 40.83% 3Y
-31.74 72.14% 5Y
-31.74 72.14% 10Y
-31.74 72.14% 20Y
SIX Swiss Exchange, Closing price Wed, Jul 16 2025
-0.30 2.39%
ISIN
CH1129677105
Symbol
MEDX
Sector

Key metrics

Basic
Market capitalization
CHF518.3m
Enterprise Value
CHF723.6m
Net debt
CHF205.3m
Cash
CHF118.1m
Shares outstanding
40.8m
Valuation (TTM | estimate)
P/E
negative | 37.0
P/S
1.1 | 1.0
EV/Sales
1.5 | 1.5
EV/FCF
19.0
P/B
1.2
Dividends
DPS
CHF0.50
Yield 1Y | 5Y
4.1% | 1.8%
Growth 1Y | 5Y
0.0% | -
Payout 1Y | 3Y
-277.8% | 1,363.6%
Increased
0 Years
Financials (TTM | estimate)
Revenue
CHF483.9m | CHF497.2m
EBITDA
CHF80.4m | CHF86.5m
EBIT
CHF18.8m | CHF26.6m
Net Income
CHF-7.4m | CHF13.8m
Free Cash Flow
CHF38.1m
Growth (TTM | estimate)
Revenue
-0.6% | 2.7%
EBITDA
9.5% | 7.6%
EBIT
25.3% | 41.6%
Net Income
-2,566.7% | 286.9%
Free Cash Flow
1,090.6%
Margin (TTM | estimate)
Gross
33.0%
EBITDA
16.6% | 17.4%
EBIT
3.9%
Net
-1.5% | 2.8%
Free Cash Flow
7.9%
Financial Health
Equity Ratio
45.7%
Return on Equity
-1.7%
ROCE
2.4%
ROIC
2.7%
Debt/Equity
0.7
More
EPS
CHF-0.2
FCF per Share
CHF0.9
Short interest
-
Employees
3k
Rev per Employee
CHF180.0k
Show more

Is Medmix a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,011 stocks worldwide.

Medmix Stock Analysis

Unlock Scores for Free

Analyst Opinions

8 Analysts have issued a Medmix forecast:

7x Buy
88%
1x Hold
13%

Analyst Opinions

8 Analysts have issued a Medmix forecast:

Buy
88%
Hold
13%

Financial data from Medmix

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
484 484
1% 1%
100%
- Direct Costs 324 324
1% 1%
67%
160 160
1% 1%
33%
- Selling and Administrative Expenses 116 116
2% 2%
24%
- Research and Development Expense 25 25
1% 1%
5%
80 80
10% 10%
17%
- Depreciation and Amortization 62 62
5% 5%
13%
EBIT (Operating Income) EBIT 19 19
25% 25%
4%
Net Profit -7.40 -7.40
2,567% 2,567%
-2%

In millions CHF.

Don't miss a Thing! We will send you all news about Medmix directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

medmix AG designs, develops and produces delivery devices for the mixing, application and injection of liquids for the healthcare, consumer and industrial end-markets. The firm operates through a number of well-known brands including Mixpac, Transcodent, Cox, MK, Medmix,Haselmeier and Geka. It operates through two business segments: Healthcare and Consumer & Industrial. The Healthcare business segment is divided into the Dental, Drug Delivery and Surgery market segments. The Dental market segment offers mixing and delivery devices for a broad range of applications, such as prosthetics, restorations, anesthetics and aesthetics. The Drug Delivery market segment offers drug delivery devices that are used to inject fertility drugs, growth hormones and to treat niche diabetes indications, osteoporosis and rare diseases. The Surgery market segment offers mixing and delivery devices are used to inject bone cement and to apply hemostatic sealants for internal and external wound treatment during surgical procedures. The Consumer & Industrial segment operates through the Industry and Beauty market segments. The Industry market segment offers dispensers, cartridges and mixers that are used in the construction, transportation (automotive, railways and aerospace), electronics assembly, infrastructure and do-it-yourself industries. The Beauty market segment offers microbrushes that are used for the application of color cosmetics, such as mascara and in other areas, such as skin care, but also in non-beauty-related areas such as cleaning devices for consumer products. The company was founded on September 9, 2021 and is headquartered in Zug, Switzerland.

Head office Switzerland
CEO René Willi
Employees 2,695
Website www.medmix.ch

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today